Frank A. Alleva is a Managing Director at Blue Owl and member of the Tax Team. In his role, he is primarily focused on product structuring, tax compliance, investor reporting and other asset management tax operational matters across the various business strategies.
Before joining Blue Owl, Frank was a Vice President at Blackstone focused on both the publicly traded company and head of retail funds tax. Prior to that, he was a Tax Manager at PwC in the Real Estate Asset Management practice. Frank began his career at KPMG in the Real Estate and Construction Tax practice.
Frank received a BS in Accounting and a MS in Taxation from St. John’s University, where he graduated magna cum laude. Frank is a licensed Certified Public Accountant in New York.
Sandip Agarwala is a Managing Director at Blue Owl and member of the Direct Lending Investment Team. In his role, he focuses on life sciences credit, royalty and growth equity investments.
Before joining Blue Owl, Sandip was a Managing Director at Longitude Capital, a life sciences focused investment firm. Prior to that, he was a Vice President at Auven Therapeutics Management. Sandip began his career as a management consultant with The Boston Consulting Group and The Frankel Group.
Sandip received his MBA in Finance and Healthcare Management from The Wharton School and holds a BSE in Systems Science and Engineering from the University of Pennsylvania.
Ilan Aharoni is a Principal at Blue Owl and member of the Direct Lending Investment Team. Based in Menlo Park, he is focused on growth-stage investing in leading technology businesses, primarily across SaaS, Infrastructure, and Security.
Before joining Blue Owl, Ilan was a Senior Associate at Vector Capital, a technology-focused private equity fund based in San Francisco. Ilan began his career as an Investment Banking Analyst at J.P. Morgan in London and San Francisco.
Ilan received a BS in International Business Administration and an MS in Finance and Investments, cum laude, from Rotterdam School of Management – Erasmus University in the Netherlands.
Joe Alongi is a Managing Director at Blue Owl and the Chief Financial Officer, Private Credit Funds. Joe is a member of the firm's Operating Committee as well as the Blue Owl Credit Operating and Valuation Committees.
Prior to joining Blue Owl in 2018, Joe was a Director at Guggenheim Partners Investment Management, where he served as a Controller in the Private Commingled Fund Accounting Group and was responsible for the accounting and reporting for various Alternative Investment Funds and CLOs. Prior to that, Joe worked within the Financial Services practice of PwC where he specialized in audits of alternative investment funds and registered investment companies.
Joe received a BS in Accounting from Villanova University and is a licensed Certified Public Accountant in New York.
Kerri Amato is a Managing Director at Blue Owl and member of the Compliance Team. Kerri is also the Chief Compliance Officer of Blue Owl Securities LLC, the firm’s limited purpose broker-dealer. In her role as head of compliance distribution, she focuses on Blue Owl’s global expansion, and in her role as CCO of Blue Owl Securities, she is responsible for the broker-dealer’s compliance program. Before joining Blue Owl, Kerri was a Managing Director at AQR Capital Management, LLC and served as the Chief Compliance Officer for AQR Investments, LLC. Kerri began her career as a Marketing Associate then transitioned to the Compliance Team at Arhnold & S. Bleichroeder Advisers LLC.
Kerri received her BBA in International Finance and Marketing from the University of Miami and holds a MBA in Finance and Marketing from Baruch College, Zicklin School of Business.
Timothy Anderson is a Managing Director at Blue Owl and member of the Healthcare Opportunities Investment Team. In his role, he focuses on investments in biotechnology, diagnostics, and digital medicine companies and sits on the Fund's Investment Committee.
Previously Tim was a co-founding member and Managing Director of Cowen Healthcare Investments, the predecessor to Blue Owl Healthcare Opportunities. Prior to his role at Cowen Healthcare Investments, Tim was a biotechnology investment banker at Cowen and Company.
He is currently a member of the Board of Directors of Lycia Therapeutics, F2G, Anaveon, Autobahn Therapeutics and Scipher Medicine. Tim previously served as a Board Member or Board Observer of Tourmaline Bio, Vectiv Bio Holdings, Therachon, Precision Biosciences, Livongo Health, Cadent Therapeutics, Cullinan Oncology and Compass Therapeutics.
Tim received a BA in both Economics and Government & Legal studies from Bowdoin College.
Pete Andreuccetti is a Principal at Blue Owl and member of the Direct Lending Investment Team. Based in New York, he is focused on investments to middle market firms across the capital structure.
Before joining Blue Owl, Pete was an Associate Director at Macquarie working on infrastructure and real assets credit. Prior to that, he was an Associate at Deutsche Bank in the Commodities Group and based in London.
Pete received an MBA from the University of Chicago Booth School of Business and a BS in Chemical Engineering from Northwestern University, where he graduated with honors.
Joanna Antkowiak is a Principal at Blue Owl and member of the Private Wealth Team. In her role, she focuses on the expansion of Blue Owl’s private wealth business across EMEA. She is responsible for establishing and nurturing strategic partnerships with key private banks, designing a strategy on entering new markets, and building the private wealth team across the region.
Before joining Blue Owl, Joanna spent nearly a decade at Blackstone, most recently as a Vice President in their Private Wealth Solutions team. Prior to that, she began her career as a Researcher at Dealogic in the Institutional Client Management team.
Joanna received her BA in International Business, with high honors, from the University of Westminster. She is a CAIA charterholder.
Matt Baker is a Managing Director at Blue Owl and member of the Direct Lending Investment Team. In his role, he is focused on the origination and execution of investment opportunities for the direct lending business.
Prior to joining Blue Owl, Matt was a Managing Director in the Private Credit Group at Goldman Sachs where he was involved in the group’s leveraged loan and mezzanine investing strategies. Prior to that, he worked at Pinnacle Agriculture Holdings as the Vice President of Business Development and Financial Planning and Analysis, Credit Suisse as a Vice President in the Financial Sponsors Group, SunTrust Robinson Humphrey as an Associate in the Syndicated and Leverage Finance Group and Lehman Brothers as an Analyst in the Private Wealth Management Group.
Matt earned an MBA from Emory University’s Goizueta Business School and holds a BA in Economics from Boston College.
Bobby Basinski is a Managing Director at Blue Owl and member of the Tax Team. Based in Short Hills, NJ, he is primarily focused on tax accounting, financial statement reporting and tax advisory.
Before joining Blue Owl, Bobby was an Executive Director at JPMorgan Chase & Co., a global financial services firm, where he specialized in tax accounting and reporting. Prior to this, Bobby was a Senior Associate at PricewaterhouseCoopers LLP in the Banking Capital Markets & Insurance group.
Bobby received a BS in Accounting from Villanova University and is a Certified Public Accountant in New York.